Statistics for Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells - Possible role of peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the pathogenesis of Huntington disease
Total visits
views | |
---|---|
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells - Possible role of peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the pathogenesis of Huntington disease | 139 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells - Possible role of peroxisome proliferator-activated receptor-gamma (PPAR gamma) in the pathogenesis of Huntington disease.pdf | 28 |
Top country views
views | |
---|---|
United States | 41 |
Chile | 32 |
Germany | 29 |
Russia | 2 |
AP | 1 |
Israel | 1 |
South Korea | 1 |
Mexico | 1 |
Vietnam | 1 |
Top city views
views | |
---|---|
Miami | 37 |
Santiago | 26 |
Concepcion | 5 |
Balingen | 4 |
Kempen | 2 |
Acre | 1 |
Alameda | 1 |
Campbell | 1 |
Hanoi | 1 |
Jacksonville | 1 |
Sacramento | 1 |
Vilsbiburg | 1 |
Zapopan | 1 |